Overview

Viatris Inc. was formed through the merger of Mylan N.V. and Upjohn, a division of Pfizer. It is a global pharmaceutical company that provides a broad range of medications, including generics and specialty drugs. The company focuses on increasing patient access to affordable medications.

Therapeutic areas

FDA compliance signals

25 FDA enforcement records linked to this company.

  • recall — Class II2026-04-15

    Failed Dissolution Specifications

  • recall — Class II2025-01-22

    Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.

  • recall — Class II2025-01-22

    Failed Impurities/Degradation Specifications: Out of specification results observed for the impurity compound B during stability testing.

  • recall — Class II2024-12-18

    Superpotent Drug and Subpotent Drug: potency failures obtained

  • recall — Class II2024-12-18

    Superpotent Drug and Subpotent Drug: potency failures obtained

  • recall — Class II2024-12-18

    Superpotent Drug and Subpotent Drug: potency failures obtained

  • recall — Class II2024-12-18

    Superpotent Drug and Subpotent Drug: potency failures obtained

  • recall — Class II2024-12-18

    Superpotent Drug and Subpotent Drug: potency failures obtained

  • recall — Class II2024-12-18

    Superpotent Drug and Subpotent Drug: potency failures obtained

  • recall — Class II2024-12-18

    Superpotent Drug and Subpotent Drug: potency failures obtained

  • recall — Class II2024-12-18

    Superpotent Drug and Subpotent Drug: potency failures obtained

  • recall — Class II2024-12-18

    Superpotent Drug and Subpotent Drug: potency failures obtained

  • recall — Class II2024-12-18

    Superpotent Drug and Subpotent Drug: potency failures obtained

  • recall — Class II2024-12-18

    Superpotent Drug and Subpotent Drug: potency failures obtained

  • recall — Class II2024-07-24

    Failed Impurities/Degradation Specifications

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.